直击业绩会丨晶泰控股上半年由盈转亏:加码自研管线投入,AI制药“卖水人”要亲自下场“淘金”?

每日经济新闻
Aug 21

8月19日晚间,港股AI制药龙头晶泰控股(02228.HK)交出了2026年中期“成绩单”。报告期内,公司实现营业收入3.94亿元,同比下降约23.9%;期内净亏损为2.25亿元,而去年同期净利润为7560.9万元。  对于业绩由盈转亏,晶泰控股在财报中解释称,由于2025年同期确认了重大管线授权合作的首笔5100万美元付款,形成较高比较基数,公司本期整体收入同比回落;剔除该重大管线授权项目影响后...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10